Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Bugianesi

Showing results (181-190 of 326) with videos related to

Pageof 33
Sort By:
Metabolism: Clinical and Experimental|July 22, 2021
Preparing for the NASH epidemic: A call to actionFasiha Kanwal, Jay H Shubrook, Zobair Younossi, et al.
Hepatology (Baltimore, Md.)|September 22, 2012
Hepatic fat loss in advanced nonalcoholic steatohepatitis: are alterations in serum adiponectin the cause?David van der Poorten, Caroline F Samer, Mehdi Ramezani-Moghadam, et al.
Frontiers in Immunology|March 12, 2024
Histidine-rich glycoprotein in metabolic dysfunction-associated steatohepatitis-related disease progression and liver carcinogenesisBeatrice Foglia, Salvatore Sutti, Stefania Cannito, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|June 30, 2024
Evaluation of Google Search Trends for Liver Diseases in EuropeAndreas Teufel, Timo Itzel, Anca Zimmermann, et al.
Gastroenterology|August 21, 2021
Preparing for the NASH Epidemic: A Call to ActionFasiha Kanwal, Jay H Shubrook, Zobair Younossi, et al.
Diabetes Care|July 27, 2021
Preparing for the NASH Epidemic: A Call to ActionFasiha Kanwal, Jay H Shubrook, Zobair Younossi, et al.
Plos One|March 2, 2017
Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitisStefania Cannito, Elisabetta Morello, Claudia Bocca, et al.
Minerva Gastroenterology|October 12, 2022
Serum glypican-3 for the prediction of survival in patients with hepatocellular carcinomaAurora Nicolosi, Silvia Gaia, Alessandra Risso, et al.
Iscience|September 6, 2022
Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver diseasePartho Sen, Olivier Govaere, Tim Sinioja, et al.
Current Oncology (Toronto, Ont.)|August 25, 2022
Liver Cancer-Specific Isoform of Serine Protease Inhibitor Kazal for the Detection of Hepatocellular Carcinoma: Results from a Pilot Study in Patients with Dysmetabolic Liver DiseaseGian Paolo Caviglia, Aurora Nicolosi, Maria Lorena Abate, et al.
Pageof 33

Showing results (181-190 of 326) with videos related to

Sort By:
Pageof 33
Metabolism: Clinical and Experimental|July 22, 2021
Preparing for the NASH epidemic: A call to actionFasiha Kanwal, Jay H Shubrook, Zobair Younossi, et al.
Hepatology (Baltimore, Md.)|September 22, 2012
Hepatic fat loss in advanced nonalcoholic steatohepatitis: are alterations in serum adiponectin the cause?David van der Poorten, Caroline F Samer, Mehdi Ramezani-Moghadam, et al.
Frontiers in Immunology|March 12, 2024
Histidine-rich glycoprotein in metabolic dysfunction-associated steatohepatitis-related disease progression and liver carcinogenesisBeatrice Foglia, Salvatore Sutti, Stefania Cannito, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|June 30, 2024
Evaluation of Google Search Trends for Liver Diseases in EuropeAndreas Teufel, Timo Itzel, Anca Zimmermann, et al.
Gastroenterology|August 21, 2021
Preparing for the NASH Epidemic: A Call to ActionFasiha Kanwal, Jay H Shubrook, Zobair Younossi, et al.
Diabetes Care|July 27, 2021
Preparing for the NASH Epidemic: A Call to ActionFasiha Kanwal, Jay H Shubrook, Zobair Younossi, et al.
Plos One|March 2, 2017
Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitisStefania Cannito, Elisabetta Morello, Claudia Bocca, et al.
Minerva Gastroenterology|October 12, 2022
Serum glypican-3 for the prediction of survival in patients with hepatocellular carcinomaAurora Nicolosi, Silvia Gaia, Alessandra Risso, et al.
Iscience|September 6, 2022
Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver diseasePartho Sen, Olivier Govaere, Tim Sinioja, et al.
Current Oncology (Toronto, Ont.)|August 25, 2022
Liver Cancer-Specific Isoform of Serine Protease Inhibitor Kazal for the Detection of Hepatocellular Carcinoma: Results from a Pilot Study in Patients with Dysmetabolic Liver DiseaseGian Paolo Caviglia, Aurora Nicolosi, Maria Lorena Abate, et al.
Pageof 33